Tag: 2022

Ochre Bio raises $30 million for RNA-based liver disease therapies

$30 million financing for RNA therapies for chronic liver diseases 

Oxford biotech raises funds to make RNA treatments for liver disease

Ochre Bio raises $30M for liver disease research

RNA therapies startup Ochre Bio lands $30M to take on chronic liver disease

A liver disease upstart with some global connections and a new R&D strategy reaps a $30M launch round

Skydivers raise almost £10,000 for children at Helen & Douglas House

A New Era in European Life Sciences Investment

Chirps, chats and Clubhouses: First-time biotech founders turn to social media for advice, investors and recruitment

Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge